Family planning

PubMed Free Full Text

Injectable contraceptives

Burkina Faso

• Frontiers in Global Women's Health
  • Determinants of DMPA-SC self-care/self-injectable contraceptive uptake among modern contraceptive users in Burkina Faso: findings from the 2021 demographic and health survey [2024]

Ghana

• Global Health: Science and Practice
  • What Distinguishes Women Who Choose to Self-Inject? A Prospective Cohort Study of Subcutaneous Depot Medroxyprogesterone Acetate Users in Ghana [2022]

Guatemala

• World Health Organization
  • Community-based providers in rural Guatemala can provide the injectable contraceptive DMPA safely : Social science policy brief [2009]

International

• BJOG: An International Journal of Obstetrics & Gynaecology
  • Self-administration of injectable contraceptives: a systematic review [2017]

• BMJ Global Health
  • Self-administration of injectable contraception: a systematic review and meta-analysis [2019]

• Contraception
  • The safety of subcutaneously administered depot medroxyprogesterone acetate (104mg/0.65mL): A systematic review [2016]

• Systematic Reviews
  • Implementation strategies to scale up self-administered depot medroxyprogesterone acetate subcutaneous injectable contraception: a scoping review [2023]

Kenya

• Frontiers in Global Women's Health
  • Moving policy to practice: role of advocacy in enabling provision of injectable contraceptives by pharmacists in Kenya [2023]

• Journal of Family & Reproductive Health
  • Multiple Logistic Regression Model for Determinants of Injectable Contraceptive Uptake Among Women of Reproductive Age in Kenya [2021]

Kenya, Rwanda

• Global Health: Science and Practice
  • Policy and programmatic considerations for introducing a longer-acting injectable contraceptive: perspectives of stakeholders from Kenya and Rwanda [2014]

Malawi

• PLOS Global Public Health
  • Health care provider and client experiences of counselling on depot medroxyprogesterone acetate subcutaneous (DMPA-SC) for self-injection in Malawi [2023]

Nigeria

• BMC Women's Health
  • Scale-up of the DMPA-SC in Nigeria: Why policy matters [2022]

Norway

• Acta Obstetricia et Gynecologica Scandinavica
  • Decreasing trends in number of depot medroxyprogesterone acetate starters in Norway – a cross-sectional study [2018]

Sub-Saharan Africa

• BMJ Global Health
  • Self-injected contraceptives: does the investment reflect women's preferences? [2022]

• Human Resources for Health
  • Provision of injectable contraceptives by community health workers in sub-Saharan Africa: a systematic review of safety, acceptability and effectiveness [2022]

Uganda

• Journal of Adolescent Health
  • Adolescent and Youth Experiences With Contraceptive Self-Injection in Uganda: Results From the Uganda Self-Injection Best Practices Project [2023]

United Kingdom

• Faculty of Sexual & Reproductive Healthcare
  • Progestogen-only Injectables

• National Institute for Health and Care Excellence
  • Long-acting reversible contraception: subcutaneous depot medroxyprogesterone acetate (DMPA-SC) [2014]

United States

• American College of Obstetricians and Gynecologists
  • Depot Medroxyprogesterone Acetate and Bone Effects [2014]

• Centers for Disease Control and Prevention
  • Update to U.S. Selected Practice Recommendations for Contraceptive Use: Self-Administration of Subcutaneous Depot Medroxyprogesterone Acetate [2021]

• LactMed
  • Medroxyprogesterone Acetate

• Obstetrics & Gynecology
  • The Role of Subcutaneous Depot Medroxyprogesterone Acetate in Equitable Contraceptive Care [2021]

WHO

• World Health Organization
  • Self-administration of injectable contraception, 2022 update [2022]
  • Self-administration of injectable contraception [2020]

{Related topics}

• Topic
  • Hormonal contraception
  • Family planning, contraception